Literature DB >> 17955262

Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy.

Minghui Qin1, Hiroyuki Kondo, Tomoko Tahira, Kenshi Hayashi.   

Abstract

Mutations in Norrin signaling genes (NDP, FZD4 and LRP5) have been found in patients with familial exudative vitreoretinopathy (FEVR) and the altered signaling is suspected to play a critical role in its pathogenesis. To better understand this relationship, we systematically performed functional analyses on previously identified single nucleotide variants of LRP5, FZD4 and NDP, utilizing the Norrin dependent Topflash reporter assay. Cell surface binding assays and protein electrophoresis analysis of Norrin were also performed. Seven causative mutations and five possibly causative but indecisive variants were examined. We found: (1) a nonsense mutation in FZD4 completely abolished its signaling activity, while single missense mutations in LRP5 and FZD4 caused a moderate level of reduction (ranging from 26 to 48, 36% on average) and a double missense mutation in both genes caused a severe reduction in activity (71%). These observations correlated roughly with clinical phenotypes. (2) A mutational effect is suggested in four of five indecisive variants by signaling reductions comparable to those of missense mutations. (3) Norrin mutants demonstrated variable effects on signal transduction, and no apparent correlation with clinical phenotypes was observed. (4) The Norrin mutants examined demonstrated impaired cell surface binding, and some may have partially lost their ability to form a complex with unknown high molecular weight material(s). Our results illustrate the nature of FEVR in relation to Norrin signaling and further suggest the complexity of its disease causing mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955262     DOI: 10.1007/s00439-007-0438-8

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.

Authors:  Xiaodong Jiao; Valerio Ventruto; Michael T Trese; Barkur S Shastry; J Fielding Hejtmancik
Journal:  Am J Hum Genet       Date:  2004-09-02       Impact factor: 11.025

2.  Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women.

Authors:  Zhen-lin Zhang; Yue-juan Qin; Jin-wei He; Qi-ren Huang; Miao Li; Yun-qiu Hu; Yu-juan Liu
Journal:  Acta Pharmacol Sin       Date:  2005-09       Impact factor: 6.150

3.  X-linked recessive familial exudative vitreoretinopathy.

Authors:  D A Plager; I K Orgel; F D Ellis; M Hartzer; M T Trese; B S Shastry
Journal:  Am J Ophthalmol       Date:  1992-08-15       Impact factor: 5.258

4.  Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.

Authors:  Andreas Ohlmann; Michael Scholz; Andreas Goldwich; Bharesh K Chauhan; Kristiane Hudl; Anne V Ohlmann; Eberhart Zrenner; Wolfgang Berger; Ales Cvekl; Mathias W Seeliger; Ernst R Tamm
Journal:  J Neurosci       Date:  2005-02-16       Impact factor: 6.167

5.  Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity.

Authors:  B S Shastry; M T Trese
Journal:  Am J Med Genet       Date:  1997-03-17

6.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

7.  Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.

Authors:  J Guo; L F Cooper
Journal:  Bone       Date:  2006-09-07       Impact factor: 4.398

8.  Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy.

Authors:  Hiroyuki Kondo; Minghui Qin; Shunji Kusaka; Tomoko Tahira; Haruyuki Hasebe; Hideyuki Hayashi; Eiichi Uchio; Kenshi Hayashi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

9.  Mutational analysis of Norrin-Frizzled4 recognition.

Authors:  Philip M Smallwood; John Williams; Qiang Xu; Daniel J Leahy; Jeremy Nathans
Journal:  J Biol Chem       Date:  2006-12-06       Impact factor: 5.157

Review 10.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

View more
  14 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.

Authors:  Maria B Lai; Chi Zhang; Jianli Shi; Verity Johnson; Lavan Khandan; John McVey; Michael W Klymkowsky; Zhe Chen; Harald J Junge
Journal:  Cell Rep       Date:  2017-06-27       Impact factor: 9.423

3.  Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR.

Authors:  Evangelia S Panagiotou; Carla Sanjurjo Soriano; James A Poulter; Emma C Lord; Denisa Dzulova; Hiroyuki Kondo; Atsushi Hiyoshi; Brian Hon-Yin Chung; Yoyo Wing-Yiu Chu; Connie H Y Lai; Mark E Tafoya; Dyah Karjosukarso; Rob W J Collin; Joanne Topping; Louise M Downey; Manir Ali; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

Review 4.  Genetic susceptibility to advanced retinopathy of prematurity (ROP).

Authors:  Barkur S Shastry
Journal:  J Biomed Sci       Date:  2010-08-25       Impact factor: 8.410

5.  Functional analysis of disease-associated polymorphism LRP5.Q89R.

Authors:  Weiming Mao; Robert J Wordinger; Abbot F Clark
Journal:  Mol Vis       Date:  2011-04-08       Impact factor: 2.367

6.  Identification of two novel LRP5 mutations in families with familial exudative vitreoretinopathy.

Authors:  Ping Fei; Qi Zhang; Luling Huang; Yu Xu; Xiong Zhu; Zhengfu Tai; Bo Gong; Shi Ma; Quanyao Yao; Jing Li; Peiquan Zhao; Zhenglin Yang
Journal:  Mol Vis       Date:  2014-03-29       Impact factor: 2.367

7.  Role of NDP- and FZD4-Related Novel Mutations Identified in Patients with FEVR in Norrin/β-Catenin Signaling Pathway.

Authors:  Shuai Han; Junhui Sun; Liwei Yang; Ming Qi
Journal:  Biomed Res Int       Date:  2020-04-27       Impact factor: 3.411

8.  Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy.

Authors:  Huiqin Yang; Shiqiang Li; Xueshan Xiao; Panfeng Wang; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2012-10-04       Impact factor: 2.367

9.  Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity.

Authors:  Hiroyuki Kondo; Shunji Kusaka; Aki Yoshinaga; Eiichi Uchio; Akihiko Tawara; Tomoko Tahira
Journal:  Mol Vis       Date:  2013-02-25       Impact factor: 2.367

Review 10.  Complex genetics of familial exudative vitreoretinopathy and related pediatric retinal detachments.

Authors:  Hiroyuki Kondo
Journal:  Taiwan J Ophthalmol       Date:  2015-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.